CLINICAL_TRIALS
withdrawal
· 2009-01-09
Clinical Trial Update: Study of ARC1779 in Patients With Acute Myocardial Infarction Undergoing PCI [Phase 2]
Summary
A Phase 2 study of ARC1779 in patients with acute myocardial infarction undergoing PCI was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Archemix Corp. | Conditions: Acute Myocardial Infarction | Phase 2 | Status: TERMINATED